|
(PQA4) Point-of-Care Test of Exposure to Hepatocellular Carcinoma Risk by V-Chip
|
1R01CA180083-01
|
$534,498
|
$534,498
|
Qin, Lidong
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
2013 Annual Meeting of the American Society for Investigative Pathology
|
1R13CA177075-01
|
$15,000
|
$3,750
|
LUSCINSKAS, FRANCIS
|
AMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY
|
|
4D Robust Optimization in Intensity-Modulated Proton Therapy
|
7K25CA168984-02
|
$125,174
|
$62,587
|
Liu, Wei
|
MAYO CLINIC ARIZONA
|
|
A Bayesian Framework for Inter-Modality Deformable Image Registration Evaluation
|
1K01CA181292-01
|
$119,534
|
$29,884
|
Castillo, Richard
|
UT MD ANDERSON CANCER CTR
|
|
A Genetic Screen for HCC Genes
|
5R01CA132962-04
|
$284,744
|
$284,744
|
LARGAESPADA, DAVID
|
UNIVERSITY OF MINNESOTA
|
|
A Multidisciplinary and Translational Approach to Hepatobiliary Malignancy
|
5K24CA139570-04
|
$186,940
|
$186,940
|
Nelson, David
|
UNIVERSITY OF FLORIDA
|
|
A Needle Guidance System for Hepatic Tumor Ablation That Fuses Real-Time Ultrasou
|
5R44CA143234-03
|
$547,270
|
$547,270
|
Razzaque, Sharif
|
INNEROPTIC TECHNOLOGY, INC.
|
|
A New Method for Improved Targeting in Image-guided Abdominal Interventions
|
5R01CA138586-04
|
$337,720
|
$337,720
|
Hata, Nobuhiko
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,117,473
|
$55,874
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Aberrantly secreted glycoproteins as markers of liver cancer
|
5U01CA168856-02
|
$316,400
|
$316,400
|
Mehta, Anand
|
DREXEL UNIVERSITY
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-37S2
|
$12,499
|
$125
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-37
|
$7,216,850
|
$72,169
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
|
1U24CA180921-01
|
$686,990
|
$137,398
|
CROWLEY, REBECCA
|
UNIVERSITY OF PITTSBURGH
|
|
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
|
5R01CA161694-02
|
$275,161
|
$275,161
|
SELL, STEWART
|
WADSWORTH CENTER
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
3U01CA121947-07S1
|
$5,600,000
|
$280,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
5U01CA121947-07
|
$6,477,537
|
$323,877
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Alliance of Glycobiologists for Detection of Cancer
|
5U01CA168926-02
|
$353,401
|
$353,401
|
GOLDMAN, RADOSLAV
|
GEORGETOWN UNIVERSITY
|
|
Altered Growth Factor Pathways in Biliary Cancer
|
2R01CA083650-11A1
|
$307,017
|
$307,017
|
SIRICA, ALPHONSE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
An Orthotopic Murine Model of HCC: Immunotolerance and Prevention
|
7R01CA164335-02
|
$296,509
|
$296,509
|
Staveley-O'Carroll, Kevin
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Analysis of a novel regulator of hepatocellular carcinoma
|
3R01CA138540-04S1
|
$8,260
|
$8,260
|
SARKAR, DEVANAND
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Analysis of a novel regulator of hepatocellular carcinoma
|
5R01CA138540-04
|
$282,853
|
$282,853
|
SARKAR, DEVANAND
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Analysis of LC-MS data to identify peptide and glycan biomarkers for hepatocellul
|
5R01CA143420-04
|
$261,371
|
$261,371
|
RESSOM, HABTOM
|
GEORGETOWN UNIVERSITY
|
|
Antibody Therapy of Cancer
|
ZIA BC 010891
|
$650,270
|
$520,216
|
Ho, Mitchell
|
CCR (NCI)
|
|
Aptamer targeting of osteopontin in hepatocellular cancer
|
5R21CA155306-02
|
$152,826
|
$152,826
|
KUO, PAUL
|
LOYOLA UNIVERSITY CHICAGO
|
|
Asian Community Cancer Health Disparities Center (ACCHDC)
|
3U54CA153513-04S1
|
$65,000
|
$10,400
|
MA, GRACE
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
Asian Community Cancer Health Disparities Center (ACCHDC)
|
5U54CA153513-04
|
$818,899
|
$131,024
|
MA, GRACE
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,207,080
|
$48,283
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Atlases to Report and Correlate Radiotherapy Dose Distributions with Outcomes
|
5R01CA129182-05
|
$405,304
|
$101,326
|
Jackson, Andrew
|
SLOAN-KETTERING INST CAN RES
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,465,171
|
$723,259
|
Custer, Mary
|
CCR (NCI)
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-24
|
$486,165
|
$4,862
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S1
|
$75,000
|
$3,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S2
|
$43,265
|
$1,731
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-07
|
$3,092,811
|
$123,712
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$708,251
|
$70,825
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biologic Basis of Disparity in Liver Cancer Survival Among Asian Americans
|
1R21CA179722-01
|
$168,200
|
$168,200
|
BOWLUS, CHRISTOPHER
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Biomarkers of Opisthorchis viverrini-induced cholangiocarcinoma
|
3R01CA155297-03S1
|
$68,569
|
$68,569
|
Brindley, Paul
|
GEORGE WASHINGTON UNIVERSITY
|
|
Biomarkers of Opisthorchis viverrini-induced cholangiocarcinoma
|
5R01CA155297-03
|
$490,037
|
$490,037
|
Brindley, Paul
|
GEORGE WASHINGTON UNIVERSITY
|
|
Biosynthesis of Selenocysteine and Its Incorporation into Protein
|
ZIA BC 010767
|
$380,000
|
$95,000
|
Hatfield, Dolph
|
CCR (NCI)
|
|
c-Myc-regulated microRNAs in normal and pathologic cellular physiology
|
2R01CA120185-07
|
$293,037
|
$146,519
|
MENDELL, JOSHUA
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer and Leukemia Group B
|
5U10CA031946-32
|
$9,816,255
|
$490,813
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA032291-32
|
$454,439
|
$22,722
|
Burstein, Harold
|
DANA-FARBER CANCER INST
|
|
Cancer and Leukemia Group B
|
5U10CA047577-26
|
$85,701
|
$4,285
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Cancer and Leukemia Group B
|
3U10CA077597-14S2
|
$85,066
|
$4,253
|
CHESON, BRUCE
|
GEORGETOWN UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA077651-16
|
$194,694
|
$9,735
|
Hudis, Clifford
|
SLOAN-KETTERING INST CAN RES
|
|
Cancer and Leukemia Group B
|
5U10CA047559-23
|
$144,968
|
$7,248
|
Shea, Thomas
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer and Leukemia Group B
|
5U10CA041287-28
|
$237,055
|
$11,853
|
KINDLER, HEDY
|
UNIVERSITY OF CHICAGO
|
|
Cancer and Leukemia Group B - Leukemia Correlative Sciences
|
5U10CA101140-11
|
$742,430
|
$37,122
|
MARCUCCI, GUIDO
|
OHIO STATE UNIVERSITY
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-16
|
$447,372
|
$22,369
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-28S1
|
$362,418
|
$7,248
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-29
|
$2,684,982
|
$53,700
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Liver Cancer for this search: $63,977,360
|